BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6422105)

  • 1. [Relationship between serum pepsinogen levels and gastric acid-pepsin secretion].
    Chang CM; Miki K; Furihata C; Kageyama T; Ichinose M; Niwa H; Oka H; Matsushima T; Takahashi K
    Nihon Shokakibyo Gakkai Zasshi; 1983 Oct; 80(10):2195-201. PubMed ID: 6422105
    [No Abstract]   [Full Text] [Related]  

  • 2. Pepsinogens, pepsins, and peptic ulcer.
    Samloff IM; Taggart RT
    Clin Invest Med; 1987 May; 10(3):215-21. PubMed ID: 3113799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Eur J Clin Pharmacol; 1988; 35(2):173-6. PubMed ID: 3142776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum group I pepsinogen levels in patients with peptic ulcer and normal subjects.
    Nakanome C; Akai H; Goto Y
    Tohoku J Exp Med; 1983 Feb; 139(2):151-8. PubMed ID: 6404006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of proximal gastric vagotomy on insulin- induced gastric H+ and pepsin secretion and serum group I pepsinogens.
    Haukland HH; Waldum HL; Johnson JA
    Scand J Gastroenterol; 1982 Jun; 17(4):555-9. PubMed ID: 6813958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aggressive factors in the pathogenesis of peptic ulcer disease.
    Richardson CT
    Scand J Gastroenterol Suppl; 1990; 174():37-43. PubMed ID: 2119515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients.
    Parente F; Lazzaroni M; Sangaletti O; Baroni S; Bianchi Porro G
    Gut; 1985 Dec; 26(12):1327-32. PubMed ID: 3936754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma pepsinogen in duodenal ulcer].
    MARTINEZ CORTES F; MORALES SANTELICES C; PORTILLA AGUILAR J
    Rev Med Hosp Gen (Mex); 1961; 24():343-8. PubMed ID: 14470493
    [No Abstract]   [Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assays for serum pepsinogens I and II using monoclonal antibodies--with data on peptic ulcer and gastric cancer.
    Huang SC; Miki K; Furihata C; Ichinose M; Shimizu A; Oka H
    Clin Chim Acta; 1988 Jun; 175(1):37-50. PubMed ID: 3168282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of pepsinogen secretion: influence of pentagastrin on pepsinogen secretion in man.
    Ten Kate RW; Tuynman HA; Festen HP; Pals G; Meuwissen SG
    Hepatogastroenterology; 1990 Feb; 37(1):124-7. PubMed ID: 2107135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of various food stimuli on serum group 1 pepsinogen (PG 1) level. Comparison with gastric secretory function].
    Kawamura T; Ishimori A; Sato T; Koizumi F
    Nihon Shokakibyo Gakkai Zasshi; 1984 Mar; 81(3):811-6. PubMed ID: 6547749
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of fundic vagotomy and cholinergic replacement on pentagastrin dose responsive gastric acid and pepsin secretion in man.
    Hirschowitz BI; Helman CA
    Gut; 1982 Aug; 23(8):675-82. PubMed ID: 6807759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pepsin release by prostaglandin E1 analogue. A potential therapeutic problem.
    Basson MD; Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Arch Surg; 1988 Apr; 123(4):431-3. PubMed ID: 3126724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pepsinogen I and duodenal ulcer].
    Marchese MA
    Arq Gastroenterol; 1988; 25(1):37-43. PubMed ID: 3066307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The behavior of urinary and hematic pepsinogen in ulcerative and neoplastic diseases of the stomach and duodenum].
    LABORANTI F; FILIPAZZI A
    Riv Patol Clin; 1961 Dec; 16():773-86. PubMed ID: 14461274
    [No Abstract]   [Full Text] [Related]  

  • 17. [Follow-up studies on gastric acid and pepsin secretion in patients with peptic ulcer (author's transl)].
    Tsukamoto Y; Nakazawa S; Segawa K; Naito Y; Kawaguchi S; Tominaga J; Chujo C; Azama S; Sugiyama H; Shimizu Y; Okada M; Tsuboi Y; Kato K; Yamada K; Muramatsu S
    Nihon Shokakibyo Gakkai Zasshi; 1980 Oct; 77(10):1547-54. PubMed ID: 6779034
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of proximal gastric vagotomy on serum pepsinogen I and II concentrations and acid secretion in duodenal ulcer patients.
    Feldman M; Blair AJ; Richardson CT; Samloff IM
    Dig Dis Sci; 1988 Jul; 33(7):824-7. PubMed ID: 3378476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sucralfate protects the ulcer from acids and pepsin].
    von Bocko Polach U
    Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum pepsin activity as a parameter of gastric acid secretion.
    Massarrat S
    Hepatogastroenterology; 1985 Aug; 32(4):185-90. PubMed ID: 3932173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.